Tribunal Adjusts Transfer Pricing & Medical Insurance Expenditure

The Tribunal partly allowed the appeal of the assessee, directing the Transfer Pricing Officer (TPO) to re-determine the arm's length price (ALP) for the international software development services transaction. Certain companies were excluded from the list of comparables, while the inclusion of others was to be reconsidered. The disallowance of group medical insurance expenditure was remanded for fresh consideration.

---

---

Issues Involved:
1. Transfer Pricing Adjustment
2. Disallowance of Group Medical Insurance Expenditure

Detailed Analysis:

1. Transfer Pricing Adjustment:
The primary dispute revolves around the inclusion and exclusion of certain companies as comparables for determining the arm's length price (ALP) of the international transaction of software development services undertaken by the assessee, Kaplan India Private Limited (KIPL).

Avani Cincom Technologies Ltd:
The assessee sought exclusion of Avani Cincom Technologies Ltd., arguing that the company earned revenue from software product sales, which affected its margins. The Tribunal noted that the TPO did not provide detailed information obtained under section 133(6) and found that the revenue from the software product named Dxchange impacted the company's margins. Consistent with previous Tribunal decisions, Avani Cincom Technologies Ltd. was excluded from the set of comparables.

Helios Matheson Limited:
The assessee argued for the exclusion of Helios Matheson Limited, citing its income from ITES activities and the absence of segmental information. The Tribunal observed that Helios Matheson failed the employee cost filter applied by the TPO and had different FAR compared to the assessee. Therefore, Helios Matheson Limited was excluded from the final list of comparables.

Ishirinfotech Limited:
The assessee contested the inclusion of Ishirinfotech Limited, which failed the 25% employee cost filter based on section 133(6) information. The Tribunal noted that the TPO did not provide detailed information and found that Ishirinfotech's FAR was different from that of the assessee. Consequently, Ishirinfotech Limited was excluded from the final set of comparables.

Megasoft Ltd:
The assessee argued for the exclusion of Megasoft Ltd., highlighting its revenue from product licenses and related revenues. The Tribunal noted that Megasoft was engaged in multifarious activities, including software product sales, and an extraordinary event of amalgamation impacted its margins. Following previous Tribunal decisions, Megasoft Ltd. was excluded from the final set of comparables.

TATA Elxsi Limited:
The assessee requested the exclusion of TATA Elxsi Limited, which was engaged in embedded product design services, industrial design, and animation. The Tribunal found that TATA Elxsi's activities were complex and included hardware design, making it incomparable to simple software development services. Therefore, TATA Elxsi Limited was excluded from the final set of comparables.

Indium Software (India) Limited and VMF Soft Tech Limited:
The assessee sought the inclusion of Indium Software (India) Limited and VMF Soft Tech Limited. The Tribunal directed the TPO/AO to reconsider the inclusion of these companies after providing the assessee an opportunity to be heard and considering all relevant material.

2. Disallowance of Group Medical Insurance Expenditure:
The assessee contested the disallowance of group medical insurance expenditure, arguing that the scheme offered by ICICI Lombard was approved by IRDA. The Tribunal directed the AO to reconsider the issue, taking into account all relevant material available in the public domain and providing the assessee an opportunity to be heard.

Conclusion:
The appeal of the assessee was partly allowed. The Tribunal directed the TPO/AO to re-determine the ALP of the international transaction of software development services after excluding certain companies from the final list of comparables and reconsider the inclusion of others. The issue of disallowance of group medical insurance expenditure was remanded for fresh consideration.

---